Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.002 | 0.0022 | 0.0028 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0024 | 0.0087 | 0.0295 |
Loa Loa (eye worm) | glutathione reductase | 0.0203 | 0.2919 | 1 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.007 | 0.0818 | 0.1042 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.007 | 0.0818 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0396 | 0.1358 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.0103 | 0.0354 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.002 | 0.0022 | 0.0268 |
Schistosoma mansoni | bromodomain containing protein | 0.0068 | 0.078 | 0.078 |
Brugia malayi | intermediate filament protein | 0.0056 | 0.0592 | 0.2028 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0058 | 0.0625 | 0.2111 |
Echinococcus multilocularis | lamin dm0 | 0.0056 | 0.0592 | 0.1998 |
Loa Loa (eye worm) | hypothetical protein | 0.0128 | 0.1734 | 0.594 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.007 | 0.0818 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0056 | 0.0592 | 0.2028 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0058 | 0.0625 | 0.7641 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.007 | 0.0818 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.007 | 0.0818 | 0.2803 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.0103 | 0.0354 |
Leishmania major | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0053 | 0.0548 | 0.0548 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0463 | 0.7038 | 0.8958 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.002 | 0.0022 | 0.0075 |
Leishmania major | DNA polymerase eta, putative | 0.002 | 0.0022 | 0.0075 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0818 | 0.2803 |
Toxoplasma gondii | thioredoxin reductase | 0.0203 | 0.2919 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.002 | 0.0022 | 0.0074 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0463 | 0.7038 | 0.8958 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Echinococcus multilocularis | musashi | 0.0056 | 0.0592 | 0.1998 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.002 | 0.0022 | 0.0075 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.007 | 0.0818 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0058 | 0.0625 | 0.2142 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0206 | 0.2962 | 1 |
Onchocerca volvulus | 0.0056 | 0.0592 | 0.3414 | |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0053 | 0.0548 | 0.1851 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.007 | 0.0818 | 0.2803 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0103 | 0.0354 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0022 | 0.0075 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0818 | 0.2803 |
Brugia malayi | Bromodomain containing protein | 0.0081 | 0.0979 | 0.3353 |
Schistosoma mansoni | zinc finger protein | 0.0021 | 0.0037 | 0.0037 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0064 | 0.0719 | 0.2426 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0356 | 0.122 |
Loa Loa (eye worm) | hypothetical protein | 0.0128 | 0.1734 | 0.594 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0058 | 0.0625 | 0.7641 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0103 | 0.0354 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0053 | 0.0548 | 0.1878 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0058 | 0.0625 | 0.0796 |
Echinococcus multilocularis | dna polymerase eta | 0.002 | 0.0022 | 0.0074 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0515 | 0.7856 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0039 | 0.0315 | 0.1063 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0052 | 0.0523 | 0.179 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0058 | 0.0625 | 0.2142 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.002 | 0.0022 | 0.035 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.007 | 0.0818 | 0.0818 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0053 | 0.0548 | 0.1851 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0515 | 0.7856 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0463 | 0.7038 | 0.8958 |
Brugia malayi | glutathione reductase | 0.0203 | 0.2919 | 1 |
Trichomonas vaginalis | glutathione reductase, putative | 0.007 | 0.0818 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0058 | 0.0625 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0058 | 0.0625 | 0.2142 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.007 | 0.0818 | 0.2763 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0024 | 0.0087 | 0.0295 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0051 | 0.0519 | 0.1779 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.002 | 0.0022 | 0.0022 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.003 | 0.018 | 0.0616 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.007 | 0.0818 | 0.2803 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.0022 | 0.0075 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0052 | 0.0523 | 0.179 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.0022 | 0.0075 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0203 | 0.2919 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0056 | 0.0592 | 0.2028 |
Plasmodium falciparum | thioredoxin reductase | 0.007 | 0.0818 | 0.2803 |
Mycobacterium ulcerans | DNA polymerase IV | 0.002 | 0.0022 | 0.0268 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0116 | 0.0399 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Mycobacterium ulcerans | DNA polymerase IV | 0.002 | 0.0022 | 0.0268 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0206 | 0.2962 | 1 |
Schistosoma mansoni | intermediate filament proteins | 0.0056 | 0.0592 | 0.0592 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.002 | 0.0022 | 0.0022 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.002 | 0.0022 | 0.0075 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0818 | 0.2803 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0103 | 0.0354 |
Plasmodium falciparum | glutathione reductase | 0.0203 | 0.2919 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0139 | 0.1907 | 0.6533 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.002 | 0.0022 | 0.0268 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0058 | 0.0625 | 0.2142 |
Schistosoma mansoni | lamin | 0.0056 | 0.0592 | 0.0592 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.007 | 0.0818 | 0.2803 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0515 | 0.7856 | 1 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.002 | 0.0022 | 0.0074 |
Plasmodium vivax | glutathione reductase, putative | 0.0203 | 0.2919 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0133 | 0.0454 |
Schistosoma mansoni | ap endonuclease | 0.0058 | 0.0625 | 0.0625 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.003 | 0.018 | 0.0616 |
Onchocerca volvulus | 0.0056 | 0.0592 | 0.3414 | |
Trypanosoma brucei | unspecified product | 0.002 | 0.0022 | 0.0075 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0203 | 0.2919 | 0.3716 |
Brugia malayi | Bromodomain containing protein | 0.0041 | 0.0355 | 0.1216 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0022 | 0.0075 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0024 | 0.0087 | 0.0087 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.002 | 0.0022 | 0.0028 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0058 | 0.0625 | 0.2142 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0515 | 0.7856 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0103 | 0.0354 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0818 | 0.2803 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.007 | 0.0818 | 0.2803 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0463 | 0.7038 | 0.8958 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0022 | 0.0075 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.002 | 0.0022 | 0.0074 |
Schistosoma mansoni | DNA polymerase eta | 0.002 | 0.0022 | 0.0022 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0103 | 0.0354 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0103 | 0.0354 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.007 | 0.0818 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0818 | 0.2803 |
Brugia malayi | hypothetical protein | 0.0128 | 0.1734 | 0.594 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.002 | 0.0022 | 0.0075 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.007 | 0.0818 | 0.2803 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0053 | 0.0548 | 0.0548 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0203 | 0.2919 | 1 |
Echinococcus multilocularis | zinc finger protein | 0.0021 | 0.0037 | 0.0125 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0051 | 0.0519 | 0.1779 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0058 | 0.0625 | 0.2142 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0116 | 0.0399 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0463 | 0.7038 | 0.8958 |
Echinococcus granulosus | dna polymerase eta | 0.002 | 0.0022 | 0.0074 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.0906 | 0.3104 |
Brugia malayi | PHD-finger family protein | 0.0027 | 0.0128 | 0.0437 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.007 | 0.0818 | 0.2803 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.007 | 0.0818 | 0.2803 |
Treponema pallidum | NADH oxidase | 0.007 | 0.0818 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.007 | 0.0818 | 0.2803 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0022 | 0.0055 | 0.0188 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0022 | 0.0075 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0818 | 0.2803 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.007 | 0.0818 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0058 | 0.0625 | 0.2142 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0053 | 0.0548 | 0.0548 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.007 | 0.0818 | 0.2803 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0429 | 0.1469 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0058 | 0.0625 | 0.2111 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.0103 | 0.0354 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.007 | 0.0818 | 0.2803 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0058 | 0.0625 | 0.7641 |
Echinococcus granulosus | lamin dm0 | 0.0056 | 0.0592 | 0.1998 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0053 | 0.0548 | 0.1878 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0139 | 0.1907 | 0.6533 |
Echinococcus granulosus | lamin | 0.0056 | 0.0592 | 0.1998 |
Plasmodium falciparum | thioredoxin reductase | 0.0203 | 0.2919 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0058 | 0.0625 | 0.7641 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Plasmodium falciparum | glutathione reductase | 0.007 | 0.0818 | 0.2803 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.007 | 0.0818 | 0.2803 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.007 | 0.0818 | 0.2763 |
Echinococcus multilocularis | lamin | 0.0056 | 0.0592 | 0.1998 |
Echinococcus multilocularis | cytoplasmic intermediate filament protein | 0.0027 | 0.0133 | 0.0448 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0261 | 0.0261 |
Leishmania major | trypanothione reductase | 0.0203 | 0.2919 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0463 | 0.7038 | 0.8958 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0261 | 0.0896 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.0103 | 0.0354 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0058 | 0.0625 | 0.7641 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0035 | 0.0261 | 0.0896 |
Schistosoma mansoni | ap endonuclease | 0.0058 | 0.0625 | 0.0625 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.007 | 0.0818 | 0.2803 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0592 | 0.2028 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0519 | 0.1779 |
Loa Loa (eye worm) | intermediate filament protein | 0.0056 | 0.0592 | 0.2028 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0818 | 0.2803 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0053 | 0.0548 | 0.1851 |
Echinococcus granulosus | zinc finger protein | 0.0021 | 0.0037 | 0.0125 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0818 | 0.2803 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0058 | 0.0625 | 0.7641 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0203 | 0.2919 | 1 |
Schistosoma mansoni | lamin | 0.0056 | 0.0592 | 0.0592 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0039 | 0.0315 | 0.1063 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0058 | 0.0625 | 0.2142 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0064 | 0.0719 | 0.2426 |
Trichomonas vaginalis | mercuric reductase, putative | 0.007 | 0.0818 | 1 |
Echinococcus granulosus | dna polymerase kappa | 0.002 | 0.0022 | 0.0074 |
Giardia lamblia | DINP protein human, muc B family | 0.002 | 0.0022 | 0.0268 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0576 | 0.1972 |
Brugia malayi | Thioredoxin reductase | 0.0203 | 0.2919 | 1 |
Echinococcus granulosus | cytoplasmic intermediate filament protein | 0.0027 | 0.0133 | 0.0448 |
Onchocerca volvulus | Huntingtin homolog | 0.0128 | 0.1734 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.0055 | 0.0055 |
Onchocerca volvulus | Huntingtin homolog | 0.0128 | 0.1734 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0139 | 0.1907 | 0.6533 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.007 | 0.0818 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0053 | 0.0548 | 0.1851 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0022 | 0.0075 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0019 | 0.0004 | 0.0015 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0058 | 0.0625 | 0.2142 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0463 | 0.7038 | 0.8958 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.007 | 0.0818 | 0.2803 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0051 | 0.0519 | 0.1779 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.007 | 0.0818 | 0.2803 |
Trypanosoma brucei | trypanothione reductase | 0.0203 | 0.2919 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0056 | 0.0592 | 0.1998 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.007 | 0.0818 | 0.2803 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.